Vectra 3D (> 40 kg)
Active substance
ATC code
Species
Dogs.
Indications
Fleas:
Treatment and prevention of flea infestation (Ctenocephalides felis and Ctenocephalides canis). The treatment prevents flea infestation for one month. It also prevents multiplication of fleas for two months after application by inhibiting egg hatching (ovicidal activity) and by inhibiting the emergence of adults from eggs laid by adult fleas (larvicidal activity).
Ticks:
The veterinary medicinal product has persistent acaricidal and repellent efficacy against tick infestations (Rhipicephalus sanguineus and Ixodes ricinus for one month, and Dermacentor reticulatus for up to three weeks).
If ticks are present when the veterinary medicinal product is applied, the ticks may not all be killed within the first 48 hours, but they may be killed within a week. To remove ticks, it is recommended to use an appropriate tick removal device.
Sand flies, mosquitoes and stable flies:
The treatment provides persistent repellent (anti-feeding) activity. It prevents biting from sand flies (Phlebotomus perniciosus), mosquitoes (Culex pipiens, Aedes aegypti) and from stable flies (Stomoxys calcitrans) for one month post-application. The treatment also provides persistent insecticidal activity for one month against mosquitoes (Aedes aegypti) and stable flies (Stomoxys calcitrans).
Dose to be administered and administration route
Dosage:
The minimum recommended dose is 6.4 mg dinotefuran/kg body weight, 0.6 mg pyriproxyfen/kg body weight and 46.6 mg permethrin/kg body weight, equivalent to 0.12 ml of the veterinary medicinal product per kg body weight.
The following table shows the size of spot-on applicator to be used according to the weight of the dog:
|
Weight of dog (kg) |
Colour of applicator cap |
Volume (ml) |
Applicator to be used |
|
|
for dogs > 40 kg |
Red |
8.0 |
1 applicator of |
Vectra 3D for dogs > 40 kg |
Method and route of administration
Spot-on use. 1 applicator per dog.
Care should be taken to apply the veterinary medicinal product only onto intact (undamaged) dog's skin.
How to apply:
Remove the spot-on applicator from the pack.
Step 1: Hold the applicator upright, placing fingers below the larger disk as shown.
Step 2: With the other hand, press downwards on the smaller disk until the 2 disks meet evenly. This will pierce the seal.
Step 3: The dog should be standing or in a comfortable position for easy application. Part the hair until the skin is visible. Apply the veterinary medicinal product (as directed in step 4 below) slowly with the tip of the applicator on the skin.
Step 4
Use according to 4a or 4b recommendation:
4a recommendation: Gently squeeze the applicator and apply the veterinary medicinal product to the skin along the dog's back, beginning between the shoulder blades, in the number of spots and order shown in the diagrams below and squeezing until the applicator is empty. Avoid superficial application to the dog’s hair. The number of application spots will depend on the body weight of the dog.
Dogs over 40 kg body weight
1 red pipette per dog to be split in 4 spots
OR
4b recommendation: Regardless of the dog’s body weight, using the applicator tip, part the hair at the base of the tail and begin applying the veterinary medicinal product directly onto the skin in a continuous line from the base of the tail along the centre of the back all the way up to the shoulder blades, as shown in the diagram, squeezing the applicator until it is empty.
Treatment schedule:
Following a single administration, the veterinary medicinal product will prevent infestation for one month. The treatment can be repeated once a month.
Adverse reactions
Erythema, pruritus or other signs of discomfort at the application site have been reported rarely.
These signs may be mild and transient. If signs persist or worsen, veterinary advice should be sought.
Behavioural disorders such as hyperactivity, vocalisation or anxiety, systemic signs such as lethargy or anorexia, and neurological signs such as muscle tremor have been reported in rare cases.
Signs of ataxia such as unsteady movement have been reported in very rare cases. Gastrointestinal signs such as vomiting or diarrhoea have also been reported very rarely.
Transient cosmetic effects (wet appearance, spiking of hair coat and deposits) at the application site have been reported very rarely, however these effects are usually not noticeable after 48 hours.
In addition, isolated reports on convulsions have been received.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 15052/5020 |
| EAN | 3411112079896 |
